Sensei Biotherapeutics, Inc. · NASDAQ:SNSE
Trails Edge Capital Partners, LP's stake in Sensei Biotherapeutics, Inc. fell to 2.00% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Trails Edge Capital Partners, LP's stake in Sensei Biotherapeutics, Inc. fell to 2.00%, 515,335 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 2.00%
- Shares
- 515,335
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Trails Edge Capital Partners, LP | 2.00% | 515,335 |
| Trails Edge Biotechnology Master Fund, LP | 2.00% | 515,335 |
| Ortav Yehudai | 2.00% | 515,335 |
Source
Related
- Sensei Biotherapeutics, Inc.
- Trails Edge Capital Partners, LP
- Sensei Biotherapeutics, Inc. shareholders
- Schedule 13G · Trails Edge Capital Partners, LP · Feb 25, 2026
- Schedule 13G/A · Stempoint Capital LP · Aug 14, 2026
- Schedule 13G · VK Services, LLC · Aug 14, 2026
- Schedule 13G/A · Caligan Partners LP · Aug 14, 2026
- Schedule 13G · Montanova Capital, LLC · Jun 23, 2026
- Schedule 13G · S2G Investments, LLC · Jun 23, 2026